Bioadaptives annual free cash flow
2014
2024
2025
Bioadaptives Free Cash Flow (FCF) History (BDPT)
Bioadaptives reported −$534,025 in free cash flow for fiscal 2025, a decrease of $284,508 from the previous fiscal year, with a free cash flow margin of −2921.68%.
View full Bioadaptives company overviewBioadaptives free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$534,025 | −$284,508 | — | −2921.68% |
| 2024 | 2024-12-31 | −$249,517 | — | — | −1969.51% |
| 2014 | 2014-12-31 | −$60,210 | — | — | — |
Bioadaptives quarterly free cash flow
Q3.14
Q3.24
Q3.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | −$151,309 | −$94,967 | — | −3266.60% |
| Q3 2024 | 2024-09-30 | −$56,342 | — | — | — |
| Q3 2014 | 2014-09-30 | $10,455 | — | — | — |
Bioadaptives free cash flow growth trends
Bioadaptives's latest reported quarter, Q3 2025, generated −$151,309 in free cash flow, a decrease of $94,967 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Bioadaptives source filings ↗